TheEdgeResearch
Home / Stocks / GENB

Generate Biomedicines, Inc. (GENB)

NASDAQ Healthcare Biotechnology
$9.54 ▼ -8.00%
Market Cap
$1.23B
Sector
Healthcare
Industry
Biotechnology
Beta
-0.14
52-Wk Range
9.4-22.67
CEO
Michael T. Nally
Country
US
Currency
USD

Generate Biomedicines, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Somerville, MA, US. The stock last traded at $9.54, down 8.00% on the session, giving a market capitalisation of $1.23B. On trailing twelve-month figures it carries a trailing P/E of -3.11, a net margin of -1290.0%. Its beta of -0.14 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-3.11
Price / Sales
58.45
Price / Book
3.22
EV / EBITDA
-4.31
Gross margin
84.5%
Operating margin
-1382.0%
Net margin
-1290.0%
Return on equity
—
Debt / equity
0.20
Current ratio
5.01
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
312
IPO date
2026-02-27
Headquarters
Somerville, MA, US
About Generate Biomedicines, Inc.

Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities. The company's pipeline includes several key candidates: GB-0895, an investigational long-acting anti-TSLP monoclonal antibody designed for bi-annual dosing in severe asthma; GB-4362, an MMAE payload neutralizer monoclonal antibody; and GB-5267, a MUC16 CAR-T cell therapy. Integral to their work is the Generate Platform, a sophisticated system engineered to be versatile across diverse therapeutic areas and protein modalities. This platform combines computational innovation with scalable biohardware, allowing them to tackle therapeutic hurdles beyond the capabilities of traditional technologies. Established in 2018, the company was initially known as Generate Biologics, Inc. before rebranding to Generate Biomedicines, Inc. in February 2020. Its headquarters are located in Somerville, Massachusetts.

Comparable companies

Generate Biomedicines, Inc. is most often compared with the following Healthcare names:

ABCLABSIINBXSTRO
More research on GENB
GENB technical analysis GENB TheEdge Score Compare against peers
Open full interactive analysis & DCF →